netFormulary South Staffordshire Joint Formulary NHS
South Staffordshire CCGs
Burton Hospital NHS Foundation Trust
Cannock Chase Hospital
County Hospital Stafford

Preferred Prescribing list for South Staffordshire CCGs, including Burton Hospital NHS Foundation Trust and
Cannock and Stafford Hospitals Foundation Trust

Useful Links

BNFSPC  Area Prescribing Group Minutes CCG Patient Group Directions and Patient Specific Directions Prescribing Commissioning
Feedback To Us Link
BNF For Children Formulary Working Group Minutes NHS England Patient Group Directions    Area Prescribing Group Newsletters High Cost Drugs
MHRA Drug Safety Updates Formulary Application Form Vaccine Update Prescribing Audits  Communications and drug discontinuations
RICaDs and ESCAs
Burton Hospital NHS Trust
Essential Shared Care Agreements
Clinical Formularies and Guidelines
Area Prescribing Group Guidelines Woundcare Formulary Antimicrobial Guidance Continence Prescribing Formulary  
CCG Formularies
North Staffs Joint Formulary Birmingham and Surrounds Formulary Derbyshire Formulary Wolverhampton Formulary  

News Feed

05/09/17 New asthma and COPD guidelines Respiratory guidelines
05/06/17 A patient information leaflet has been produced to give sick day rules for medications in order to avoid dehydration Link to medicines and dehydration patient leaflet
05/06/17 Biosimilar Insulin glargine Abasaglar® added to formulary Biosimilar Insulin statement
04/04/17 All new updated CCG PGDS now available CCG PGDS
21/03/17 Three new ESCAS Penicllamine, Sodium authoriomalate and Sulfasalazine
26/1/17 Three new ESCAS now available for Burton Hospitals Methotrexate, Leflunomide, Azathioprine and a RICad for Sacubitril valsartan (Entresto)

>>> more news


  1. The Preferred Prescribing List for the various therapeutic sections of  the British National Formulary (BNF) can be accessed via the links

   2.     PDF How to use guide

   3.   Drugs are colour coded according to the following criteria:


Status Description
Red Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  
Amber Second-line drugs. Either more clinically or cost effective drugs are available or use should be restricted to certain groups (including ESCA's) or specialist initiation groups. They may be prescribed within Primary and Secondary Care  
Amber 1 Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care.  
Amber 2 Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement) or a RICaD (Rationale for Initiation, Continuation and Discontinuation)
Green Suitable first-line drugs for implementation in Primary Care  

   Visits = 99531